Crossmark

Pharmacological convergence reveals a lipid pathway that regulates C. elegans lifespan

Crossref DOI link: https://doi.org/10.1038/s41589-019-0243-4

Published Online: 2019-03-25

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Alice L.

Lum, Kenneth M.

Lara-Gonzalez, Pablo

Ogasawara, Daisuke http://orcid.org/0000-0002-2178-4698
Cognetta, Armand B III

To, Alan

Parsons, William H.

Simon, Gabriel M.

Desai, Arshad

Petrascheck, Michael http://orcid.org/0000-0002-1010-145X
Bar-Peled, Liron

Cravatt, Benjamin F. http://orcid.org/0000-0001-5330-3492
License Information

Text and Data Mining valid from 2019-03-25
More Information

Article History

Received: 28 June 2018

Accepted: 1 February 2019

First Online: 25 March 2019

Competing interests

: B.F.C. is a founder and advisor to Abide Therapeutics, a biotechnology company interested in developing serine hydrolase inhibitors and therapeutics.